€9.44
Your prediction
Financial data and news for Dynavax
sharewise wants to provide you with the best news and tools for Dynavax, so we directly link to the best financial data sources.
Financials
News
Why Dynavax Stock Soared Today
Shares of Dynavax Technologies (NASDAQ: DVAX) popped on Wednesday after the vaccine maker struck a deal to be acquired by Sanofi (NASDAQ: SNY).
As of 3:00 p.m. EST, Dynavax's stock price was up
Dynavax (DVAX) Q2 Revenue Jumps 29%
Dynavax Technologies (NASDAQ:DVAX), a biotechnology company focused on vaccines, released its results for the second quarter of 2025 on August 7, 2025. The company posted GAAP revenue of $95.4


